Related Experiment Video
Updated: Aug 3, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
Long-term sulfamethoxazole-trimethoprim in Wegener's granulomatosis
1Ear, Nose, and Throat Department, Southend Hospital, Westcliff-on-Sea, England.
Abstract:
Since 1985, a number of reports have highlighted the effectiveness of a short course of sulfamethoxazole-trimethoprim as an adjuvant to immunosuppressive drugs in the treatment of Wegener's granulomatosis. We report our experience with long-term sulfamethoxazole-trimethoprim therapy in patients with Wegener's granulomatosis. We describe recent advances in the pathogenesis of Wegener's granulomatosis, suggest a complementary mechanism of action of sulfamethoxazole-trimethoprim, and advocate long-term sulfamethoxazole-trimethoprim therapy as a treatment option in Wegener's granulomatosis.
Insights
Long-term sulfamethoxazole-trimethoprim therapy shows promise for Wegener's granulomatosis treatment. This approach may offer a valuable option for managing this autoimmune condition.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Wegener's granulomatosis is a rare autoimmune disease.
- Short-term sulfamethoxazole-trimethoprim has been used as an adjuvant therapy.
Observation:
- This study reports on the experience with long-term sulfamethoxazole-trimethoprim therapy.
- Recent advances in understanding Wegener's granulomatosis pathogenesis are discussed.
Findings:
- Long-term administration of sulfamethoxazole-trimethoprim is presented as a viable treatment option.
- A complementary mechanism of action for sulfamethoxazole-trimethoprim is proposed.
Implications:
- Long-term sulfamethoxazole-trimethoprim therapy could be a beneficial treatment strategy for Wegener's granulomatosis.
- Further research into the drug's mechanism in this condition is warranted.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Rocky Mountain Spotted Fever
Antiprotozoal Agents
